Coots M C, Miller M A, Glueck H I
Thromb Haemost. 1981 Dec 23;46(4):734-9.
The plasmas of six patients with prolonged activated partial thromboplastin times were studied in detail. In five of the six, the Russell's viper venom and prothrombin times were likewise prolonged. Five of the patients had documented systemic lupus erythematosus; one lacked the necessary criteria for this diagnosis. On quantitation, factor XI was decreased in all six; factors X and XII were diminished in five of the six. When tested for inhibitory activity, plasma from each of the patients prolonged the celite eluate inhibition test for factor XII and/or XI inhibition. In the formation of the Xa-V-phospholipid-Ca2+ complex (prothrombinase), factors X and Xa were inhibited to a greater degree than factor V or the phospholipid. Finally, each plasma was isofocused, the inhibitory fractions were identified and the clotting factor specificity of each inhibitory peak was determined. Fractions inhibitory against factors XI and XII isofocused with the IgG in each patient's plasma. Based on the data presented from these six patients, the "lupus inhibitor" is in fact a heterogeneous collection of inhibitors directed against factors XII, XI and X rather than a homogeneous entity.
对6例活化部分凝血活酶时间延长患者的血浆进行了详细研究。6例中的5例,蝰蛇毒时间和凝血酶原时间同样延长。5例患者确诊为系统性红斑狼疮;1例缺乏该诊断的必要标准。定量分析显示,所有6例患者的因子XI均降低;6例中的5例因子X和因子XII减少。检测抑制活性时,每位患者的血浆均延长了硅藻土洗脱液对因子XII和/或因子XI的抑制试验。在Xa-V-磷脂-Ca2+复合物(凝血酶原酶)的形成过程中,因子X和Xa比因子V或磷脂受到更大程度的抑制。最后,对每份血浆进行等聚焦,鉴定抑制组分并确定每个抑制峰的凝血因子特异性。对因子XI和因子XII有抑制作用的组分与每位患者血浆中的IgG等聚焦。根据这6例患者提供的数据,“狼疮抑制剂”实际上是针对因子XII、因子XI和因子X的多种抑制剂的集合,而非单一实体。